Otsuka (OTCMKTS:OTSKY) Sees Large Volume Increase – Here’s Why

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) shares saw an uptick in trading volume on Wednesday . Approximately 107,123 shares changed hands during mid-day trading, an increase of 180% from the previous session’s volume of 38,276 shares.The stock last traded at $37.95 and had previously closed at $38.16.

Otsuka Stock Down 1.0%

The company has a current ratio of 2.21, a quick ratio of 1.65 and a debt-to-equity ratio of 0.05. The stock has a market cap of $40.57 billion, a P/E ratio of 15.17, a PEG ratio of 2.76 and a beta of 0.02. The firm has a 50-day simple moving average of $36.61 and a two-hundred day simple moving average of $35.06.

Otsuka (OTCMKTS:OTSKY) last released its quarterly earnings results on Friday, July 31st. The company reported $0.70 EPS for the quarter, beating the consensus estimate of $0.51 by $0.19. Otsuka had a net margin of 15.50% and a return on equity of 12.86%. The business had revenue of $4.41 billion for the quarter, compared to the consensus estimate of $3.95 billion. Otsuka has set its FY 2026 guidance at 2.119-2.119 EPS. Equities research analysts expect that Otsuka Holdings Co., Ltd. – Unsponsored ADR will post 2.23 earnings per share for the current fiscal year.

Otsuka Company Profile

Otsuka Holdings Co, Ltd. is a Japan-based healthcare and consumer products holding company whose businesses focus on pharmaceuticals, nutraceuticals and other consumer health products. Through its operating companies, the group researches, develops, manufactures and markets prescription medicines for areas including psychiatry, oncology, cardiovascular disease and nephrology.

Otsuka’s consumer health portfolio includes products such as Pocari Sweat hydration beverages, Oronamin C nutritional drinks, CalorieMate balanced nutrition products and Nature Made dietary supplements.